Quick Answer
Skye Bioscience, Inc. reported Common Stock Shares Outstanding of 33.38 million shares for the year ending 2025.
- Skye Bioscience, Inc. showed an increase of +7.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Skye Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: 3.15 million shares | Q3 2013: 3.15 million shares | Q4 2013: 3.62 million shares | Q1 2014: 3.62 million shares | Q2 2014: 3.62 million shares | Q3 2014: 3.62 million shares | Q3 2014: 11.77 million shares | Q1 2015: 16.27 million shares | Q2 2015: 16.27 million shares | Q3 2015: 18.08 million shares | Q1 2016: 19.91 million shares | Q2 2016: 19.91 million shares | Q3 2016: 19.91 million shares | Q1 2017: 27.31 million shares | Q2 2017: 30.33 million shares | Q3 2017: 30.67 million shares | Q1 2018: 132.41 million shares | Q2 2018: 132.70 million shares | Q3 2018: 133.45 million shares | Q1 2019: 133.91 million shares | Q2 2019: 134.10 million shares | Q3 2019: 134.10 million shares | Q1 2020: 183.21 million shares | Q2 2020: 183.21 million shares | Q3 2020: 250.07 million shares | Q1 2021: 367.64 million shares | Q2 2021: 396.08 million shares | Q3 2021: 476.11 million shares | Q1 2022: 495.93 million shares | Q2 2022: 495.93 million shares | Q3 2022: 495.93 million shares | Q1 2023: 971.55 million shares | Q2 2023: 971.55 million shares | Q3 2023: 12.34 million shares | Q1 2024: 28.06 million shares | Q2 2024: 28.07 million shares | Q3 2024: 30.34 million shares | Q1 2025: 30.97 million shares | Q2 2025: 30.99 million shares | Q3 2025: 30.99 million shares.
- Over the full 15 years of available data (2012 to 2025), Skye Bioscience, Inc.'s Common Stock Shares Outstanding has grown by 1,220.6%.
- Historical annual values: Fiscal year 2025: 33.38 million shares | Fiscal year 2024: 30.97 million shares | Fiscal year 2023: 12.35 million shares | Fiscal year 2022: 3.65 million shares | Fiscal year 2021: 476.11 million shares | Fiscal year 2020: 288.07 million shares | Fiscal year 2019: 182.90 million shares | Fiscal year 2018: 133.91 million shares | Fiscal year 2017: 33.62 million shares | Fiscal year 2016: 21.56 million shares | Fiscal year 2015: 19.90 million shares | Fiscal year 2014: 16.00 million shares | Fiscal year 2013: 7.77 million shares | Fiscal year 2013: 3.62 million shares | Fiscal year 2012: 2.53 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: